Science Explorer Back to mapMap

Most cited papers from MRC Holland (Netherlands)

What are the most cited papers from MRC Holland (Netherlands)?

The most cited paper from MRC Holland (Netherlands) is "Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification" (Jan P. Schouten, 2002), with 2,709 citations. Next come "High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs" (961) and "Characterization of human disease phenotypes associated with mutations in TREX1 , RNASEH2A , RNASEH2B , RNASEH2C , SAMHD1 , ADAR , and IFIH1" (617).

Showing 50 of 60 papers. Every paper with more than 69 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification Jan P. Schouten · Nucleic Acids Research Open access 15 Jun 2002 2,709
2 High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs Sven Rottenberg, Janneke E. Jaspers, Ariena J. Kersbergen et al. · Proceedings of the National Academy of Sciences Open access 29 Oct 2008 961
3 Characterization of human disease phenotypes associated with mutations in TREX1 , RNASEH2A , RNASEH2B , RNASEH2C , SAMHD1 , ADAR , and IFIH1 Yanick Joseph Crow et al. · American Journal of Medical Genetics Part A Open access136 authors 16 Jan 2015 617
4 Fanconi anemia is associated with a defect in the BRCA2 partner PALB2 Bing Xia, Josephine C. Dorsman, Najim Ameziane et al. · Nature Genetics 31 Dec 2006 470
5 Methylation-Specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences Anders O.H. Nygren · Nucleic Acids Research Open access 2 Aug 2005 398
6 Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer Sven Rottenberg, Anders O.H. Nygren, Marina Pajic et al. · Proceedings of the National Academy of Sciences Open access 11 Jul 2007 305
7 High proportion of large genomic deletions and a genotype–phenotype update in 80 unrelated families with juvenile polyposis syndrome Stefan Aretz, Dietlinde Stienen, Siegfried Uhlhaas et al. · Journal of Medical Genetics Open access 14 Sep 2007 247
8 Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients on behalf of the NCRI Haemato-oncology CSG et al. · Leukemia ReviewOpen access 6 Jun 2017 240
9 The innovative organization Willem J. Vrakking · Long Range Planning Apr 1990 237
10 Increasing the Yield in Targeted Next-Generation Sequencing by Implicating CNV Analysis, Non-Coding Exons and the Overall Variant Load: The Example of Retinal Dystrophies Tobias Eisenberger et al. · PLoS ONE Open access 12 Nov 2013 231
11 Germline CDH1 deletions in hereditary diffuse gastric cancer families Carla Oliveíra et al. · Human Molecular Genetics Open access 24 Jan 2009 224
12 Abnormal offspring following in vitro production of bovine preimplantation embryos: A field study A.M. van Wagtendonk-de Leeuw, B.J.G Aerts, J.H.G. den Daas · Theriogenology Apr 1998 199
13 Deletion and duplication screening in the DMD gene using MLPA Tanja Lalic, Rolf H. A. M. Vossen, Jordy Coffa et al. · European Journal of Human Genetics 20 Jul 2005 193
14 MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas Judith W. M. Jeuken, Sandra J B Cornelissen, Martine Vriezen et al. · Laboratory Investigation Open access 14 Aug 2007 182
15 REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31 Christian Beetz et al. · Brain Open access 5 Mar 2008 181
16 Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach J J P Gille, Frans B.L. Hogervorst, Gerard Pals et al. · British Journal of Cancer Open access Oct 2002 169
17 Phenotype and genotype in 101 males with X-linked creatine transporter deficiency Jiddeke M. van de Kamp et al. · Journal of Medical Genetics Open access 3 May 2013 168
18 Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency Nils Peter Krone et al. · The Journal of Clinical Endocrinology & Metabolism Open access 8 Dec 2011 166
19 Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis W. Arnout van Hattem, Lodewijk A.A. Brosens, Wendy W.J. de Leng et al. · Gut 4 Jan 2008 163
20 Copy number variation at theFCGRlocus includesFCGR3A, FCGR2CandFCGR3Bbut notFCGR2AandFCGR2B Willemijn B. Breunis, Edwin van Mirre, Judy Geissler et al. · Human Mutation 23 Mar 2009 157
21 A/T mutagenesis in hypermutated immunoglobulin genes strongly depends on PCNAK164 modification Petra Langerak, Anders O.H. Nygren, Peter H.L. Krijger et al. · The Journal of Experimental Medicine Open access 30 Jul 2007 156
22 An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions Emmanuelle Clappier et al. · Leukemia 25 Sep 2013 155
23 Two-color multiplex ligation-dependent probe amplification: Detecting genomic rearrangements in hereditary multiple exostoses Stefan J. White, Geraldine R. Vink, Marjolein Kriek et al. · Human Mutation Open access 2004 152
24 Multiplex Ligation-dependent Probe Amplification (MLPA) in Tumor Diagnostics and Prognostics Hömig-Hölzel Cornelia, Suvi P. Savola · Diagnostic Molecular Pathology 30 Oct 2012 145
25 Rapid, high throughput prenatal detection of aneuploidy using a novel quantitative method (MLPA) Howard Robert Slater, D L Bruno, H Ren et al. · Journal of Medical Genetics Open access Dec 2003 132
26 Sequential gene promoter methylation during HPV-induced cervical carcinogenesis Florianne E Henken, Saskia M. Wilting, René Overmeer et al. · British Journal of Cancer Open access 30 Oct 2007 131
27 Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) robustly detects and distinguishes 11p15 abnormalities associated with overgrowth and growth retardation Richard H. Scott, Jenny B. Douglas, Linda Baskcomb et al. · Journal of Medical Genetics 15 Oct 2007 127
28 An overview of L-2-hydroxyglutarate dehydrogenase gene (L2HGDH) variants: a genotype-phenotype study Marjan E. Steenweg et al. · Human Mutation Open access 5 Jan 2010 126
29 Perceptions of Mental Health and Help-Seeking Behavior in an Urban Community in Vietnam: An Explorative Study Lia van der Ham, Pamela Wright, Thang Van Vo et al. · Community Mental Health Journal Open access 16 Mar 2011 120
30 Evaluation of multiplex ligation‐dependent probe amplification as a method for the detection of copy number abnormalities in B‐cell precursor acute lymphoblastic leukemia Claire J. Schwab, Lisa R. Jones, Helen Morrison et al. · Genes Chromosomes and Cancer 2 Sep 2010 119
31 Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis Carmen M. Anadon, Sònia Guil, Laia Simó‐Riudalbas et al. · Oncogene Open access 7 Dec 2015 117
32 Detailed analysis of 22q11.2 with a high density MLPA probe set G R Jalali, Jacob A. S. Vorstman, Ab Errami et al. · Human Mutation Open access 21 Nov 2007 117
33 Myoclonus-dystonia: significance of largeSGCEdeletions Anne Grünewald et al. · Human Mutation Open access 18 Jan 2008 117
34 The sensitivity of linear regression coefficients’ confidence limits to the omission of a confounder Carrie Hosman, Ben B. Hansen, Paul W. Holland · The Annals of Applied Statistics Open access Jun 2010 116
35 Intragenic deletions and a deep intronic mutation affecting pre-mRNA splicing in the dihydropyrimidine dehydrogenase gene as novel mechanisms causing 5-fluorouracil toxicity André B. P. Kuilenburg, Judith Meijer, Adri N. P. M. Mul et al. · Human Genetics Open access 28 Aug 2010 115
36 Poly(ADP-Ribose) Polymerase-1 Inhibitor Treatment Regresses Autochthonous Brca2/p53 -Mutant Mammary Tumors In vivo and Delays Tumor Relapse in Combination with Carboplatin Trevor Hay, James R. Matthews, Lucie Pietzka et al. · Cancer Research 21 Apr 2009 113
37 “Atypical” Pleomorphic Lipomatous Tumor David Creytens, Thomas Mentzel, Liesbeth Ferdinande et al. · The American Journal of Surgical Pathology 6 Sep 2017 109
38 Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix Saskia M. Wilting, PJF Snijders, Gerrit A. Meijer et al. · The Journal of Pathology 14 Mar 2006 109
39 A new molecular mechanism for severe myoclonic epilepsy of infancy: Exonic deletions in SCN1A John C. Mulley, Paul V. Nelson, Sílvia Guerrero et al. · Neurology 25 Sep 2006 102
40 Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes Cathy Beatrice Moelans, Roel A. de Weger, Hanneke N. Monsuur et al. · Modern Pathology Open access 14 May 2010 95
41 KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer Laia Simó‐Riudalbas et al. · Cancer Research Open access 24 Jul 2015 95
42 Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness Esther H. Lips, Nadja Laddach, Suvi P. Savola et al. · Breast Cancer Research Open access 27 Oct 2011 94
43 Moderate Increase in Mdr1a/1b Expression Causes In vivo Resistance to Doxorubicin in a Mouse Model for Hereditary Breast Cancer Marina Pajic, Jayasree Kaveri Iyer, Ariena J. Kersbergen et al. · Cancer Research 4 Aug 2009 94
44 Atypical spindle cell lipoma: a clinicopathologic, immunohistochemical, and molecular study emphasizing its relationship to classical spindle cell lipoma David Creytens, Joost van Gorp, Suvi P. Savola et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 22 Mar 2014 94
45 DNA profiling of primary serous ovarian and Fallopian tube carcinomas with array comparative genomic hybridization and multiplex ligation‐dependent probe amplification ME Nowee, AM Snijders, DAP Rockx et al. · The Journal of Pathology 31 Jul 2007 93
46 High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model Maria J. Worsham, Gerard Pals, Jan P. Schouten et al. · Breast Cancer Research and Treatment 30 Nov 2005 90
47 The impact of SF3B1 mutations in CLL on the DNA-damage response G. Doreen te Raa, I. A. M. Derks, Veronika Navrkalová et al. · Leukemia Open access 5 Nov 2014 90
48 Coordinating marketing and manufacturing in ETO companies Paul A. Konijnendijk · International Journal of Production Economics Nov 1994 88
49 Genetic subtyping of Fanconi anemia by comprehensive mutation screening Najim Ameziane, Abdellatif Errami, France Léveillé et al. · Human Mutation Open access 2007 87
50 Sensitivity and Acquired Resistance of BRCA1;p53-Deficient Mouse Mammary Tumors to the Topoisomerase I Inhibitor Topotecan Serge A.L. Zander, Ariena J. Kersbergen, Eline van der Burg et al. · Cancer Research 10 Feb 2010 85

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.